Evidence map›Paper›PMID 39082001›Full record

ReviewFrontiers in dementia2023

Assessing behavioral and psychological symptoms of dementia: a comprehensive review of current options and future perspectives.

Federico Emanuele Pozzi, Luisa Calì, Carlo Ferrarese, Ildebrando Appollonio, Lucio Tremolizzo

Abstract readReview
In one paragraph

Review in Frontiers in dementia, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Brexpiprazole's impacts on patients and caregivers in agitation in Alzheimer's dementia.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025
    Trial
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Federico Emanuele PozziDepartment of Neurology, Fondazione IRCCS San Gerardo dei Tintori, Monza, Italy.
Luisa CalìSchool of Medicine and Surgery, University of Milano-Bicocca, Milan, Italy.
Carlo FerrareseDepartment of Neurology, Fondazione IRCCS San Gerardo dei Tintori, Monza, Italy.
Ildebrando AppollonioDepartment of Neurology, Fondazione IRCCS San Gerardo dei Tintori, Monza, Italy.
Lucio TremolizzoDepartment of Neurology, Fondazione IRCCS San Gerardo dei Tintori, Monza, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The behavioral and psychological symptoms of dementia (BPSD) are a heterogeneous set of challenging disturbances of behavior, mood, perception, and thought that occur in almost all patients with dementia. A huge number of instruments have been developed to assess BPSD in different populations and settings. Although some of these tools are more widely used than others, no single instrument can be considered completely satisfactory, and each of these tools has its advantages and disadvantages. In this narrative review, we have provided a comprehensive overview of the characteristics of a large number of such instruments, addressing their applicability, strengths, and limitations. These depend on the setting, the expertise required, and the people involved, and all these factors need to be taken into account when choosing the most suitable scale or tool. We have also briefly discussed the use of objective biomarkers of BPSD. Finally, we have attempted to provide indications for future research in the field and suggest the ideal characteristics of a possible new tool, which should be short, easy to understand and use, and treatment oriented, providing clinicians with data such as frequency, severity, and triggers of behaviors and enabling them to find appropriate strategies to effectively tackle BPSD.

Indexed as

assessmentbehaviorBPSDdementiascales

Identifiers

PMID39082001
PMCPMC11285590

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.